Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 16 unusual trades.
Delving into the details, we found 56% of traders were bullish, while 31% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $61,685, and 14 were calls, valued at $1,503,372.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $70.0 for Moderna, spanning the last three months.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $30.0 to $70.0 in the last 30 days.
Moderna 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | SWEEP | BULLISH | 09/19/25 | $11.0 | $10.95 | $11.0 | $45.00 | $345.4K | 1.9K | 315 |
| MRNA | CALL | TRADE | BEARISH | 01/15/27 | $23.0 | $21.35 | $21.75 | $40.00 | $261.0K | 2.4K | 120 |
| MRNA | CALL | SWEEP | BEARISH | 01/17/25 | $2.4 | $1.9 | $1.9 | $45.50 | $234.8K | 977 | 1.2K |
| MRNA | CALL | SWEEP | NEUTRAL | 03/21/25 | $1.12 | $0.96 | $1.12 | $70.00 | $112.0K | 3.6K | 14 |
| MRNA | CALL | TRADE | BEARISH | 06/18/26 | $22.7 | $21.5 | $21.98 | $35.00 | $109.9K | 141 | 50 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Following our analysis of the options activities associated with Moderna, we pivot to a closer look at the company's own performance.
Present Market Standing of Moderna
- With a trading volume of 1,750,577, the price of MRNA is up by 8.77%, reaching $46.3.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 44 days from now.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
